Jump to content

Drilldown: Medicines

Pharmacopedia
BrowseCategoriesLog in

Choose a table:


Medicines > generic : 1cP-LSD or 2C-B or Prednisolone (and prednisolone sodium phosphate, acetate, etc.)

Use the filters below to narrow your results.

generic: (Click arrow to add another value)
brand:
None (1) · Nexus, Eroxan (historical, late-1980s through mid-1990s) (1) · Prelone, Pediapred, Orapred ODT, Millipred, Veripred (1)
classes:
2C-x series (1) · Classic Psychedelic (1) · Lysergamide (1) · Phenethylamine (1) · Psychedelic (1) · Research material (1) · [[:Category:Corticosteroids|Corticosteroid]] (1) · [[:Category:Glucocorticoids|Glucocorticoid (intermediate-acting)]] (1) · [[:Category:Immunosuppressants|Immunosuppressant]] (1)
mechanism:
5-HT2A partial agonist (1) · Prodrug of LSD; 5-HT2A agonist (1) · '"`UNIQ--vote-000008BE-QINU`"' Preferred over prednisone in advanced hepatic dysfunction where hepatic 11β-HSD1 activation is impaired. Liquid formulations are the workhorse pediatric oral corticosteroid for asthma and croup'"`UNIQ--ref-000008BF-QINU`"'. (1)
uses:
None (2) · '"`UNIQ--vote-000008C0-QINU`"', '"`UNIQ--vote-000008C1-QINU`"', '"`UNIQ--vote-000008C2-QINU`"', '"`UNIQ--vote-000008C3-QINU`"' (1)
starting dose:
None (2) · Pediatric 1-2 mg/kg/d (max 60 mg) PO for asthma exacerbation; adult dosing similar to prednisone milligram-for-milligram (~1:1 potency) (1)
preparations:
None (2) · 5 mg tablets; 5 mg/5 mL, 10 mg/5 mL, 15 mg/5 mL oral solutions (sweetened pediatric); 5 mg/5 mL syrup; ophthalmic 0.12%, 1% suspensions and 1% solution (1)
fda max:
None (2) · Indication-specific (1)
routes:
None (1) · IM (1) · insufflated (1) · IV (prednisolone sodium phosphate) (1) · ophthalmic (1) · Oral (2) · PR (1)
onset:
None (1) · 45-75 min (oral) (1) · Hours (1)
duration:
None (1) · 4-8 h (1) · Biologic 12-36 hours (intermediate-acting) (1)
halflife:
None (1) · Not well characterized (1) · Plasma 2-3 hours; biologic ~18-36 hours'"`UNIQ--ref-000008C4-QINU`"' (1)
bioavailability:
None (1) · Not well characterized (1) · ~70% (oral)'"`UNIQ--ref-000008C5-QINU`"' (1)
pregnancy:
None (1) · Not established (1) · Use when benefits outweigh; small association with oral clefts debated.<sup class="pcp-cn" title="This claim needs a citation.">&#91;[[Pharmacopedia:Citation needed|citation&nbsp;needed]]&#93;</sup> (1)
legal:
None (1) · [[USLegal:DEA Schedule I|Schedule I]] (United States) (1) · [[USLegal:Prescription only|Rx-only]] in US (1)

Showing below up to 3 results in range #1 to #3.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

2


View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"